PNEUMOCYSTIS JIROVECII PNEUMONIA IN HOSPITALIZED CANCER PATIENTS: INCIDENCE, RISK FACTORS, AND PROPHYLAXIS

被引：0
|
作者：
Van Hook, Reed
Mantha, Aditya
Rhoads, Sarah L.
Spradlin, Megan
Pons, Shelby
Mccollister, Bruce
Mueller, Scott
Kannappan, Arun
Maloney, James P.
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.597
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：801A / 802A
页数：2
相关论文
共 50 条
  • [41] Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (06) : 491 - 491
  • [42] Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole
    Yukawa, Kazutoshi
    Nagamoto, Yasutsugu
    Watanabe, Hirofumi
    Funaki, Masamoto
    Iwahashi, Mitsuhiro
    Yamana, Jiro
    Sasaki, Rie
    Yamana, Seizo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (07) : 355 - 360
  • [43] Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection
    Kim, Soo Jung
    Lee, Jinwoo
    Cho, Young-Jae
    Park, Young Sik
    Lee, Chang-Hoon
    Yoon, Ho
    Lee, Sang-Min
    Yim, Jae-Joon
    Lee, Jae Ho
    Yoo, Chul-Gyu
    Lee, Choon-Taek
    Kim, Young Whan
    Han, Sung Koo
    Kim, Hong Bin
    Park, Jong Sun
    JOURNAL OF INFECTION, 2014, 69 (01) : 88 - 95
  • [44] The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis
    Isidori, Alessandro
    Merli, Francesco
    Angrilli, Francesco
    Ferrara, Felicetto
    Alesiani, Francesco
    Visani, Giuseppe
    LEUKEMIA & LYMPHOMA, 2011, 52 (01) : 148 - 149
  • [45] Outbreak of Pneumocystis jirovecii Pneumonia Despite the Use of Routine Prophylaxis
    de Sandes-Freitas, T. V.
    da Silva, V. P.
    de Oliveira, F. S. V.
    Tedesco-Silva, H.
    Medina-Pestana, J. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 391 - 391
  • [46] 'Once weekly trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia prophylaxis in children with cancer'
    McMullan, Brendan
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (05) : 415 - 415
  • [47] Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
    Ramirez-Perea, Nuria
    Moran-Castano, Claudia
    Perez-Molina, Jose A.
    PNEUMONIA, 2024, 16 (01)
  • [48] Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
    Nuria Ramírez-Perea
    Claudia Moran-Castaño
    Jose A. Perez-Molina
    Pneumonia, 16
  • [49] Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients
    Brakemeier, S.
    Duerr, M.
    Bachmann, F.
    Schmidt, D.
    Gaedeke, J.
    Budde, K.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 2924 - 2930
  • [50] All Patients with Leukemia Are Not Equally at Risk of Contracting Pneumocystis jirovecii Pneumonia
    Antoine, Roux
    Caroline, Bornstain
    Francois, Vincent
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (01): : E9 - E9
12345